← FDA Drug Approvals (Drugs@FDA)
METOLAZONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NE RX PHARMA · Approved 2022-10-25
Drug application
- FDA Application #
ANDA216216
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METOLAZONE
- Generic name
- METOLAZONE
- Active ingredients
- METOLAZONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NE RX PHARMA
- Manufacturer
- Aarkish Pharmaceuticals NJ Inc.
- First approval
- 2022-10-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown